NCT01332539 An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy Status COMPLETED Phase N/A
NCT01332513 An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation. Status COMPLETED Phase PHASE1
NCT01332500 Treximet ™ Pharmacy Budget Impact Model Database Validation Study Status COMPLETED Phase N/A
NCT01332487 Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia Status COMPLETED Phase N/A
NCT01332474 JCP Study of Investigation of Patient Background Characteristics Status COMPLETED Phase N/A
NCT01332461 Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies Status COMPLETED Phase N/A
NCT01332448 Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials Status COMPLETED Phase N/A
NCT01332435 Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use Status COMPLETED Phase N/A
NCT01332422 Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric) Status COMPLETED Phase N/A
NCT01332409 Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone) Status COMPLETED Phase N/A
NCT01332370 Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone Status COMPLETED Phase N/A
NCT01332357 Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit Status COMPLETED Phase N/A
NCT01332344 Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids Status COMPLETED Phase N/A
NCT01332292 Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients Status COMPLETED Phase PHASE2
NCT01331694 Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT01330966 Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Status COMPLETED Phase PHASE2
NCT01330303 SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin Status COMPLETED Phase PHASE1